ADIPOR1 and colorectal carcinoma: However, the opposite evidence has shown that adiponectin plasma levels are inversely associated with the risk of CRC [13], and that adiponectin can suppress the cell proliferation of colon cancer via AdipoR1- and -R2-mediated AMPK activation[19].